The court's decision is based on a ruling from 2013, when Sanofi was fined 40.6 million euros for actions against generic drug manufacturers. The court found that the impact of these practices persisted until 2021, although the anti-competitive behavior lasted only five months. CNAM will receive 126.2 million euros for reimbursements and fees, plus 24.5 million euros in damages. Sanofi is reviewing the ruling and considers the possibility of an appeal to the Supreme Court.
Sources
Latest News
23:48
Prince Harry says he would enlist in the British Army again and warns that Europe must be prepared in the face of Russia
23:16
A Romanian man without a license stole a car and fled from police in Spain / The chase ended in a head-on collision
22:50
Hakeem Jeffries will lead the U.S. House of Representatives, becoming the first Black politician to hold the position
22:21
Eugen Tomac calls for reforming public administration and says that the option of eight regions can be analyzed
22:02
Traian Băsescu says Marian Neacșu will be the “executive prime minister” of the Luca Niculescu Government
See more news